Structure-Based Design of Potent and Selective 3-Phosphoinositide-Dependent Kinase-1 (PDK1) Inhibitors
Year: 2011
Type: article
Source: Journal of Medicinal Chemistry
DOI: 10.1021/jm101527u
Authors: Jesús R. Medina, Christopher J. Becker, Charles W. Blackledge, Celine Duquenne, Yanhong Feng, Seth W. Grant, Dirk Heerding, William H. Li, William H. Miller, Stuart P. Romeril, Daryl Scherzer, Arthur Shu, Mark A. Bobko, Antony R. Chadderton, Melissa Dumble, Christine M. Gardiner, Seth Gilbert, Qi Liu, Sridhar K. Rabindran, Valery Sudakin, Hong Xiang, Pat G. Brady, Nino Campobasso, Paris Ward, Jeffrey M. Axten
Institution: GlaxoSmithKline (United States)
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2017544644
